Fast Track Management of Primary Thyroid Lymphoma in the Very Elderly Patient.
FDG PET- CT
MRI
anaplastic thyroid carcinoma
core needle biopsy
metastasis to thyroid
neck mass
primary thyroid lymphoma
prognostic nomogram
thyroid malignancy
ultrasonography
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
15 06 2023
15 06 2023
Historique:
received:
15
05
2023
revised:
06
06
2023
accepted:
07
06
2023
medline:
29
6
2023
pubmed:
27
6
2023
entrez:
27
6
2023
Statut:
epublish
Résumé
A rapid growing cervical mass mobile while swallowing is the most common clinical presentation of severe thyroid malignancy. A 91-year-old female patient with a history of Hashimoto thyroiditis presented with clinical compressive neck symptoms. The patient had gastric Maltoma diagnosed that was surgically resected thirty years ago. A straightforward process was needed to reach full histological diagnosis and initiate prompt therapy. Ultrasound (US) showed a 67 mm hypoechoic left thyroid mass with reticulated pattern without signs of locoregional invasion. Percutaneous trans isthmic US-guided 18G core needle biopsy (CNB) disclosed diffuse large B cell lymphoma of the thyroid gland. FDG PET revealed two distinct thyroid and gastric foci (both SUVmax 39.1). Therapy was initiated rapidly to decrease clinical symptoms in this aggressive stage III primitive malignant thyroid lymphoma. The prognostic nomogram was calculated by using a seven-item scale, which disclosed a one-year overall survival rate of 52%. The patient underwent three R-CVP chemotherapy courses, then refused further treatment and died within five months. Real-time US-guided CNB approach led to rapid patient's management that was tailored to patient's characteristics. Transformation of Maltoma into diffuse large B cell lymphoma (DLBCL) into two body areas is deemed to be extremely rare.
Identifiants
pubmed: 37366918
pii: curroncol30060435
doi: 10.3390/curroncol30060435
pmc: PMC10297318
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
5816-5827Références
Eur J Endocrinol. 2022 Aug 02;187(3):K33-K38
pubmed: 35900324
World J Surg. 1992 Jul-Aug;16(4):604-9; discussion 609-10
pubmed: 1413831
Thyroid. 2022 May;32(5):552-559
pubmed: 35229626
Curr Opin Otolaryngol Head Neck Surg. 2023 Apr 1;31(2):83-88
pubmed: 36912220
Am J Clin Pathol. 2020 Jan 2;153(2):156-164
pubmed: 31584614
Front Endocrinol (Lausanne). 2023 Feb 09;14:1064050
pubmed: 36843586
J Clin Oncol. 2005 Jul 20;23(21):4643-51
pubmed: 15837966
Pol J Radiol. 2016 Jun 07;81:268-9
pubmed: 27354880
Korean J Radiol. 2011 May-Jun;12(3):400-1
pubmed: 21603302
Presse Med. 2014 Dec;43(12 Pt 1):1387-8
pubmed: 25307442
World J Surg Oncol. 2009 Apr 17;7:40
pubmed: 19374744
Thyroid. 2005 Jul;15(7):742-3
pubmed: 16053393
Cytopathology. 2021 Jul;32(4):523-526
pubmed: 33606321
Lancet Oncol. 2011 May;12(5):460-8
pubmed: 21482186
Thyroid. 1993 Summer;3(2):93-9
pubmed: 8369658
Ann Surg Treat Res. 2015 Dec;89(6):295-9
pubmed: 26665123
Histopathology. 2021 Mar;78(4):508-519
pubmed: 32897542
Cancers (Basel). 2022 Jun 19;14(12):
pubmed: 35740683
J Pathol Transl Med. 2020 Jan;54(1):64-86
pubmed: 31964112
Bull Cancer. 2013 Oct;100(10):1031-42
pubmed: 24077086
Head Neck. 2022 Jun;44(6):1277-1300
pubmed: 35274388
Transl Cancer Res. 2023 Mar 31;12(3):515-524
pubmed: 37033341
Cancers (Basel). 2020 Sep 10;12(9):
pubmed: 32927794
Quant Imaging Med Surg. 2023 Feb 1;13(2):1213-1220
pubmed: 36819272
Blood. 2016 Apr 28;127(17):2082-92
pubmed: 26989205
N Engl J Med. 2016 Sep 15;375(11):1054-67
pubmed: 27626519
AJR Am J Roentgenol. 1990 May;154(5):1079-85
pubmed: 2108546
Thyroid. 2012 Mar;22(3):258-68
pubmed: 22313412
Eur Radiol. 2017 Mar;27(3):1186-1194
pubmed: 27311538
Arch Otolaryngol Head Neck Surg. 2008 May;134(5):536-8
pubmed: 18490577
Hematol Oncol. 2017 Jun;35 Suppl 1:49-53
pubmed: 28591412
Ann Endocrinol (Paris). 2023 May;84(3):374-381
pubmed: 36963756
Am J Clin Oncol. 2015 Aug;38(4):338-42
pubmed: 23799287
Thyroid. 2016 Aug;26(8):1061-7
pubmed: 27256107
Eur Radiol. 2018 Sep;28(9):3848-3860
pubmed: 29589112
J Natl Compr Canc Netw. 2022 Apr;20(4):322-334
pubmed: 35390768
J Clin Oncol. 2014 Sep 20;32(27):3048-58
pubmed: 25113771
Cytojournal. 2005 Dec 09;2:21
pubmed: 16336672
Onco Targets Ther. 2018 Apr 19;11:2251-2257
pubmed: 29719407
BMC Endocr Disord. 2021 Oct 24;21(1):213
pubmed: 34689780
J Ultrasound Med. 2012 Apr;31(4):589-94
pubmed: 22441916
AJR Am J Roentgenol. 2003 Jul;181(1):272-4
pubmed: 12818872
Eur Thyroid J. 2017 Sep;6(5):225-237
pubmed: 29167761
Radiat Med. 2002 Jan-Feb;20(1):9-15
pubmed: 12002606
J Endocrinol Invest. 2022 Apr;45(4):815-824
pubmed: 34865184
Am J Surg Pathol. 2000 May;24(5):623-39
pubmed: 10800981
Front Endocrinol (Lausanne). 2022 Sep 20;13:971249
pubmed: 36204100
J Clin Med. 2023 Apr 04;12(7):
pubmed: 37048792
Cancer. 2001 Feb 15;91(4):629-35
pubmed: 11241227
Eur J Surg Oncol. 2021 Jun;47(6):1364-1369
pubmed: 33642087
Front Oncol. 2022 Apr 05;12:854755
pubmed: 35463338
Medicine (Baltimore). 2019 Apr;98(17):e15439
pubmed: 31027146
Clin Oncol (R Coll Radiol). 2020 Sep;32(9):553-561
pubmed: 32684503
Ann Oncol. 2011 Jan;22(1):156-164
pubmed: 20587509